ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway
2017 · Lipids in Health and Disease · 23 citations
https://doi.org/10.1186/s12944-017-0611-6
Z
Zhang Hai-fen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
320
Citations
8
h-index
7
i10-index
Zhang Hai-fen is an academic researcher from Tianjin Energy Investment Group (China). The author has contributed to research in topics: Dialysis and Renal Disease Management & Membrane Separation Technologies & Central Venous Catheters and Hemodialysis. The author has an h-index of 8, co-authored 92 publications.
ORCID: 0000-0002-0213-6636Papers by this author
worksA pilot study of thiamin and folic acid in hemodialysis patients with cognitive impairment
2021 · Figshare · 8 citations
https://doi.org/10.6084/m9.figshare.14680514.v1
Efficacy and safety of polysaccharide iron complex capsules compared with iron sucrose in hemodialysis patients: study protocol for a randomized, open-label, positive control, multicenter trial (IHOPE)
2021 · Trials · 7 citations
https://doi.org/10.1186/s13063-021-05663-1
The initial attempt at home hemodialysis in mainland China
2022 · BMC Nephrology · 6 citations
https://doi.org/10.1186/s12882-022-03018-9
Research hotspots and development trends in volume management of peritoneal dialysis patients: a bibliometrics and visual analysis up to 2022
2023 · International Urology and Nephrology · 1 citations
https://doi.org/10.1007/s11255-023-03869-7
A pilot study of thiamin and folic acid in hemodialysis patients with cognitive impairment
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14680514
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat